+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hematological Drugs Market Research Reports

Essential Thrombocythemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Essential Thrombocythemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
US Thrombotic Thrombocytopenic Purpura (TTP) - Epidemiology Forecast to 2030 - Product Thumbnail Image

US Thrombotic Thrombocytopenic Purpura (TTP) - Epidemiology Forecast to 2030

  • Drug Pipelines
  • October 2021
  • 50 Pages
  • United States
From
US Thrombotic Thrombocytopenic Purpura (TTP) Market Insight, Epidemiology and Market Forecast -2030 - Product Thumbnail Image

US Thrombotic Thrombocytopenic Purpura (TTP) Market Insight, Epidemiology and Market Forecast -2030

  • Report
  • October 2021
  • 110 Pages
  • United States
From
Hemlibra (Emicizumab-kxwh) - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Hemlibra (Emicizumab-kxwh) - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Nplate (Romiplostim) Romiplate - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Nplate (Romiplostim) Romiplate - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Bleeding Disorders Drugs Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Thumbnail Image

Bleeding Disorders Drugs Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • May 2024
  • 180 Pages
  • Global
From
Hemoglobinopathies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Hemoglobinopathies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • April 2024
  • 180 Pages
  • Global
From
Fibrin Sealant Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Fibrin Sealant Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 174 Pages
  • Global
From
Sickle Cell Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Sickle Cell Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • October 2023
  • 182 Pages
  • Global
From
India Dexamethasone Market, Competition, Forecast & Opportunities, 2019-2029 - Product Thumbnail Image

India Dexamethasone Market, Competition, Forecast & Opportunities, 2019-2029

  • Report
  • October 2023
  • 71 Pages
  • India
From
Heparin-Induced Thrombocytopenia Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Thumbnail Image

Heparin-Induced Thrombocytopenia Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • October 2023
  • 178 Pages
  • Global
From
Bleeding Disorders Treatment Market By Drug Type, By Disease Type, By Distribution Channel, By End User By Region, Competition, Forecast & Opportunities, 2027 - Product Thumbnail Image

Bleeding Disorders Treatment Market By Drug Type, By Disease Type, By Distribution Channel, By End User By Region, Competition, Forecast & Opportunities, 2027

  • Report
  • September 2022
  • 114 Pages
  • Global
From
Polycythemia Vera Drug Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F - Product Thumbnail Image

Polycythemia Vera Drug Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F

  • Report
  • May 2024
  • 187 Pages
  • Global
From
Hemoglobinopathies - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Hemoglobinopathies - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 100 Pages
  • Global
From
Warm Autoimmune Hemolytic Anemia (WAIHA) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Warm Autoimmune Hemolytic Anemia (WAIHA) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • March 2024
  • 134 Pages
  • Global
From
US Sickle Cell Disease - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

US Sickle Cell Disease - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • August 2023
  • 150 Pages
  • United States
From
Sickle Cell Disease - Competitive landscape, 2023 - Product Thumbnail Image

Sickle Cell Disease - Competitive landscape, 2023

  • Report
  • May 2023
  • 196 Pages
  • Global
From
Thrombocytopenia - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Thrombocytopenia - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • September 2022
  • 225 Pages
  • Global
From
Thrombocytopenia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Thrombocytopenia - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 112 Pages
  • Global
From
Chemotherapy-induced thrombocytopenia (CIT) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chemotherapy-induced thrombocytopenia (CIT) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders. The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more